title: WITHDRAWN: Medicinal and injection therapies for mechanical neck disorders.
authors.affiliation: Department of Clinical Development, MRL - Merck, RY34-B272, 126 E. Lincoln Ave, Rahway, NJ, USA, 07065.
authors.forename: Paul Michael J
authors.initials: PM
authors.lastname: Peloso
authors.forename: Anita
authors.initials: A
authors.lastname: Gross
authors.forename: Ted
authors.initials: T
authors.lastname: Haines
authors.forename: Kien
authors.initials: K
authors.lastname: Trinh
authors.forename: Charles H
authors.initials: CH
authors.lastname: Goldsmith
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Burnie
mesh_terms: D000779:Anesthetics, Local / Q000008:administration & dosage*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage; D002908:Chronic Disease; D006801:Humans; D008012:Lidocaine / Q000008:administration & dosage; D008775:Methylprednisolone / Q000008:administration & dosage; D019547:Neck Pain / Q000188:drug therapy*; D009465:Neuromuscular Agents / Q000008:administration & dosage; D011619:Psychotropic Drugs / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D014911:Whiplash Injuries / Q000188:drug therapy*
chemical_list: D000779:Anesthetics, Local; D000894:Anti-Inflammatory Agents, Non-Steroidal; D009465:Neuromuscular Agents; D011619:Psychotropic Drugs; D008012:Lidocaine; D019274:Botulinum Toxins, Type A; D008775:Methylprednisolone